Related Experiment Video
Updated: Aug 6, 2026

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
Protease mutations in HIV-1 non-B strains infecting drug-naive villagers in Cameroon
Frank A J Konings1, Ping Zhong, Moise Agwara
1Department of Microbiology, New York University School of Medicine, New York, New York 10010, USA.
Abstract:
To describe the presence of protease inhibitor (PI) resistance-associated mutations and subtype distribution in drug-naive villagers of six provinces of Cameroon, we sequenced the protease (PR) gene (297 bp) of 128 viruses. Secondary PI resistance-associated mutations were identified at five sites: L10I/V (16%), K20R (8%), M36I (98%), L63P (13%), and V77I (6%). No primary mutation in the PR was identified. Of the 128 specimens analyzed, subtypes A (11%), C(2%), D (6%), F2 (3%), G (6%), H (0.8%), J (6%), and CRF02_AG (60%) were identified. The mutations identified were not characteristic to any particular subtype. The absence of primary mutations, in addition to the few secondary mutations, gives good perspectives for PI treatment interventions in these rural areas.
Related Concept Videos
Retrovirus Life Cycles
Viral Mutations
Inhibitors of Virion Maturation and Assembly

